✦ LIBER ✦

Experience with vincristine, doxorubicin, and dexamethasone (VAD) chemotherapy in adults with refractory acute lymphocytic leukemia

✍ Scribed by Hagop M. Kantarjian; Ronald S. Walters; Michael J. Keating; Bart Barlogie; Kenneth B. McCredie; Emil J. Freireich

Book ID: 102670450
Publisher: John Wiley and Sons
Year: 1989
Tongue: English
Weight: 585 KB
Volume: 64
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19890701)64:1<16::aid-cncr2820640104>3.0.co;2-o

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of the hyperfractionated cycloph

Results of the hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimen in elderly patients with acute lymphocytic leukemia

✍ Susan O'Brien; Deborah A. Thomas; Farhad Ravandi; Stefan Faderl; Sherry Pierce; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB 👁 1 views

Acute lymphocytic leukaemia in the elder

Acute lymphocytic leukaemia in the elderly: characteristics and outsome with the vincristine-adriamycin-dexamethasone (VAD) regimen

✍ Hagop M. Kantarjian; Susan O'Brien; Terry Smith; Elihu H. Estey; Miloslav Berran 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 513 KB

Phase II study of sphingosomal vincristi

Phase II study of sphingosomal vincristine in patients with recurrent or refractory adult acute lymphocytic leukemia

✍ Deborah A. Thomas; Andreas H. Sarris; Jorge Cortes; Stefan Faderl; Susan O'Brien 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 2 views

Avascular necrosis of bone after adult a

Avascular necrosis of bone after adult acute lymphocytic leukemia treatment with methotrexate, vincristine, L-asparaginase, and dexamethasone (MOAD)

✍ Hui, Laifong; Wiernik, Peter H. 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 432 KB 👁 1 views

Four of 55 (7%) adult acute lymphocytic leukemia patients, age 27-58 years, who were treated with methotrexate, vincristine, L-asparaginase, and dexamethasone (MOAD) developed avascular necrosis (AVN) of one or both femoral heads 16-39 months after beginning treatment. All patients were treated with

A four-year experience with anthracyclin

A four-year experience with anthracycline, cytosine arabinoside, vincristine and prednisone combination chemotherapy in 325 adults with acute leukemia

✍ Dr. M. J. Keating; T. L. Smith; K. B. McCredie; G. P. Bodey; E. M. Hersh; J. U. 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 996 KB

Relation between the duration of remissi

Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate–cytarabine regimen

✍ Mary Ann Weiser; Maria E. Cabanillas; Marina Konopleva; Deborah A. Thomas; Sherr 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 339 KB 👁 1 views

## Abstract ## BACKGROUND Hyperglycemia, which is not uncommon during the treatment of acute lymphocytic leukemia (ALL), has been shown to be an independent predictor of adverse outcomes among hospitalized patients with undiagnosed diabetes; it also may have the potential to affect leukemic cell p